(1 - 12 from 14
)
BRIEF-First Patient Treated In Mapi Pharma's Phase II Clinical Trial Of ...
www.reuters.com
Jan 30 (Reuters) - Mapi Pharma Ltd: * FIRST PATIENT TREATED IN MAPI PHARMA'S PHASE II CLINICAL TRIAL OF GA DEPOT FOR ...
First Patient Treated in Mapi Pharma’s Phase IIa Clinical Trial of...
article.wn.com
GA Depot is a long-acting depot formulation injection of Glatiramer Acetate given once a month rather than daily or thrice weekly as in the.
Mapi Pharma Treats 1st RRMS Patient with Once-A-Month GA Depot
multiplesclerosisnewstoday.com
Read more about Mapi Pharma Treats 1st RRMS Patient with Once-A-Month GA Depot, an experimental injectable, reported better than Copaxone®.
First Patient Treated in Mapi Pharma's Phase II Clinical Trial of GA...
www.marketscreener.com
Study is being conducted on strength of prior Phase II clinical trial that showed strong efficacy in RRMS patients who switched from Copaxone® to once-monthly...
sorted by relevance / date